IPO Ideas logoIPO Ideas
Explore IPOSubscriptionGMPAbout UsBlogs
Explore IPOSubscriptionGMPAbout UsBlogs
Unlisted IdeasIPO Ideas
IPO Ideas is 100% Safe and Secure!

Your Trust, Our Priority – Empowering You with Confidence

Welcome to IPO Ideas — your trusted gateway to IPO bidding and smart investing. We're a passionate team dedicated to making equity investing simpler, faster, and more secure for everyone.

Our mission is to empower retail investors with a user-friendly platform that brings clarity, convenience, and control to the IPO process. From secure bidding to live GMP tracking and allotment updates — everything you need is just a few clicks away.

PRODUCTS

  • Unlisted Ideas

COMPANY

  • About Us
  • Blog
  • Privacy Policy
  • Terms & Conditions
  • Legal & Regulatory

QUICK LINKS

  • Customer Service
  • Fraud Awareness
  • Sitemap

FOLLOW US

Advertiser Disclosure

We offer two types of advertising on our website: display advertisements related to brokers and IPOs, and affiliate links that redirect users to a stock broker’s website.

We have partnerships with brokers, and when you become a client of a broker through our affiliate links, we may receive an affiliate commission. We do not work with individual clients after you click on affiliate links.

We do not provide tips, recommendations, or buy/sell calls. All information published on this website is for educational and knowledge sharing purposes only. Our broker reviews are completely unbiased, and the final choice remains yours.

We provide up-to-date information on IPOs, buybacks, NCDs, SGBs, and rights issues. GMP data is displayed strictly for informational and news purposes only. We do not work with or trade through GMP operators.

© Copyright 2026 | All Rights Reserved | IPO Ideas

mahamaya lifesciences limited
SMEBSECLOSED

mahamaya lifesciences limited IPO

MAHALIFEISIN: INE0U9D01019
Listed at
116
0.00%

IPO Overview

Mahamaya lifesciences limited IPO is a SME public issue offered through a Fixed Price issue with a total issue size of ₹70.44 Cr. The IPO price band is set at ₹108 to ₹114 per share, and retail investors can apply with a minimum investment of ₹2.78 L as per IPO guidelines.
The Mahamaya lifesciences limited IPO opens on 11 Nov 2025 and closes on 13 Nov 2025. The IPO allotment is expected to be finalized on 14 Nov 2025, and the equity shares are proposed to be listed on BSE on 18 Nov 2025.
Investors can refer to the Mahamaya lifesciences limited IPO RHP-DRHP for detailed information. The issue is managed by Oneview Corporate Advisors Pvt.Ltd. as the book running lead manager, while Kfin Technologies Limited is the registrar to the IPO. Before investing, market participants often review IPO details, valuation, PE ratio, financials, and risk factors.

Price Band
₹108 to ₹114
Issue Size
70.44 Cr
Lot Size
1200Min 2 Lots
P/E Ratio
0x
Min Investment
₹2.78 L

About Company

Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration and export of finest crop protection products and bioproducts for crop & soil health management and to help the farming community for more productivity.

The company specializes in manufacturing pesticide formulations and supplying bulk products to Indian agrochemical companies and multinational corporations (MNCs).

The company imports carefully researched molecules, registers them with the Central Insecticides Board, and markets them as technical and value-added formulations for domestic manufacturers and multinational corporations (MNCs).

The company has invested in global product registrations, with active markets in countries like the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey, offering high-quality products and data support for registrations.

Product Portfolio:


Bulk Formulations Sales: Acetamiprid, SP Buprofezin, SC Emamectin benzoate, SG Imidacloprid, SC Paraquat Dichloride.
Technical Sales: Acetamiprid Technical 99% Min, Atrazine Technical 95% Min, Imidacloprid Technical 95% Min, Emamectin Benzoate Technical 95% Min.
Branded Sales (Major own branded products): MAYAMRIT GR, MAYAMRIT SL, MAYAGIBB, UCHIT EW 370
Export Sales- Formulations: Wiper (Sulphur 80% WDG), Lancha (Pendimethalin 50% EC), Tolfen (Tolfenpyrad 15% EC), Typic (80% Sulphur WG).


Competitive Strengths:


Experienced management team consisting of experts.
Capability to introduce vital products for Indian Agriculture.
Development of export opportunities of products.
Ability to develop brands.
Cordial relationships with suppliers of raw materials.
Core values focused on achieving sustainability through innovative approaches.

Investment Objective

Purchase of Equipment for existing Formulation plant

Funding capital expenditure towards setting up of a new technical manufacturing plant

Construction of Warehouse Building and Purchase of Machinery

Funding working capital requirement of our Company

General Corporate purposes

Important Dates

Issue Opens
11 Nov 2025
Issue Closes
13 Nov 2025
Allotment
14 Nov 2025
Listing
18 Nov 2025

Financial Performance

Loading chart...

IPO Lot Size

CategoryLotsSharesAmount
S-HNI (Min)22,400₹2,78,400
S-HNI (UPI)33,600₹4,17,600
S-HNI (Max)78,400₹9,74,400
B-HNI (Min)89,600₹11,13,600
RHP Document
DHRP Document

Issue Details

Issue Type
FP
Face Value
₹10
Lead Managers
Oneview Corporate Advisors Pvt.Ltd.
Min Quantity
2,400
Company Promoters
Mr. Krishnamurthy GanesanMrs. Lalitha KrishnamurthyMr. Prashant Krishnamurthy are the Promoters of the company.
Website
https://www.mahamayalifesciences.com/
Email
cs@mahamayalifesciences.com
Phone
+91-1146561474
Address
Mahamaya Lifesciences Ltd.
Unit No: DPT – 033, Ground Floor,
Plot No: 79 – 80, DLF Prime Tower,
Block, Okhla, Phase – 1
Delhi, New Delhi, 110020

Registrar

Registrar Name
Kfin Technologies Limited
Email
reachus@kfintech.com
Phone
4067162222
Address
KFintech, Tower-B, Plot No 31 & 32,
Financial District, Nanakramguda, Gachibowli,
Hyderabad, Telangana India - 500 032.
Website
https://kosmic.kfintech.com/ipostatus/

Mahamaya lifesciences limited IPO is a public issue in which the company offers its equity shares to investors through the stock exchange. The IPO allows retail investors, HNIs, and institutional investors to participate.

The IPO price band of Mahamaya lifesciences limited IPO is ₹108 to ₹114 per share, as mentioned in the issue details.

The minimum investment in Mahamaya lifesciences limited IPO is ₹278400, based on the minimum lot size applicable for retail investors.

The lot size of Mahamaya lifesciences limited IPO is 1200 shares per lot, and applications must be made in multiples of this lot size.

Mahamaya lifesciences limited IPO opens on 11 Nov 2025 and closes on 13 Nov 2025, as per the announced IPO schedule.

The Mahamaya lifesciences limited IPO subscription status shows how many times the issue has been subscribed across retail, HNI, and institutional categories during the IPO period.

The Mahamaya lifesciences limited IPO GMP (Grey Market Premium) today is around ₹undefined, reflecting current grey market activity before listing.

Mahamaya lifesciences limited IPO GMP is currently negative, indicating prevailing sentiment in the grey market. GMP may change daily based on demand.

A positive Mahamaya lifesciences limited IPO GMP may suggest potential listing interest, while actual listing performance depends on subscription levels and overall market conditions.

From a retail investor perspective, Mahamaya lifesciences limited IPO is evaluated based on pricing, lot size, subscription trends, and market sentiment. Investors should assess these factors before applying.

The Mahamaya lifesciences limited IPO listing date is expected to be 18 Nov 2025, subject to completion of allotment and exchange procedures.

The expected listing price of Mahamaya lifesciences limited shares depends on demand, subscription response, GMP trends, and overall market sentiment at the time of listing.

Mahamaya lifesciences limited IPO allotment status can be checked online once the allotment process is completed using PAN, application number, or DP ID details.

Mahamaya lifesciences limited IPO is categorized as a SME IPO based on the exchange and issue structure.

Yes, Mahamaya lifesciences limited IPO subscription figures and GMP may change during the issue period and before listing due to market activity and investor demand.